We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GTEN:NASDAQGores Holdings X, Inc. Analysis

Data as of 2026-05-22 - not real-time

$10.35

Latest Price

8/10Risk

Risk Level: High

Executive Summary

GTEN is trading in a narrow range around $10.35 with its 20‑day, 50‑day and 200‑day SMAs virtually overlapping (≈$10.35), indicating a very flat price structure. Technical signals are mixed: RSI sits at 60 (above 50, hinting at modest momentum), the MACD histogram is negative and the signal line is labeled bearish, while the overall trend is still classified as bullish. Volume is slipping (current daily volume ~9.5k versus a 10‑day average of ~54k), raising concerns about liquidity. Fundamentally, the company reports zero revenue, negative operating cash flow, and a book value per share of –$0.63, yet it carries a trailing PE of ~61 versus an industry average of ~17 and a wildly negative price‑to‑book ratio, underscoring severe overvaluation. The beta is near zero and 30‑day volatility is low (~1.9 %), but the market sentiment index shows “Extreme Greed,” suggesting speculative buying pressure. The only material news is a recent Barron’s grading note, which adds little substantive insight.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD histogram despite flat bullish trend
  • Extreme overvaluation (PE ~61 vs industry ~17)
  • Diminishing trading volume raising liquidity concerns

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential merger or business combination catalyst typical of SPAC‑style shells
  • Continued bullish trend classification with modest RSI support
  • Lack of operating earnings and negative cash flow limiting intrinsic value

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Speculative nature of a shell company without revenue
  • High overvaluation and negative book value
  • Low beta and low volatility but persistent fundamental deficiencies

Key Metrics & Analysis

Financial Health

P/E Ratio60.9
P/B Ratio-16.5
Op. Cash Flow$-1229315
Industry P/E16.8

Technical Analysis

TrendBullish
RSI60.3
Support$10.34
Resistance$10.40
MA 20$10.35
MA 50$10.30
MA 200$10.29
MACDBearish
VolumeDecreasing
Fear & Greed Index91.43

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.02
Volatility1.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.